Abstract:Importance: Although depression is a common psychiatric disorder, its underlying biological basis remains poorly understood. Pairing depression polygenic scores with the results of clinical laboratory tests can reveal biological processes involved in depression etiology and in the physiological changes resulting from depression.Objective: To characterize the association between depression polygenic scores and an inflammatory biomarker, ie, white blood cell count.Design, Setting, and Participants: This genetic association study was conducted from May 19, 2019, to June 5, 2021, using electronic health record data from 382 452 patients across 4 health care systems. Analyses were conducted separately in each health care system and meta-analyzed across all systems. Primary analyses were conducted in Vanderbilt University Medical Center's biobank. Replication analyses were conducted across 3 other PsycheMERGE sites: Icahn School of Medicine at Mount Sinai, Mass General Brigham, and the Million Veteran Program. All patients with available genetic data and recorded white blood cell count measurements were included in the analyses. Primary analyses were conducted in individuals of European descent and then repeated in a population of individuals of African descent.Exposures: Depression polygenic scores.Main Outcomes and Measures: White blood cell count.Results: Across the 4 PsycheMERGE sites, there were 382 452 total participants of European ancestry (18.7% female; median age, 57.9 years) and 12 383 participants of African ancestry (61.1% female; median age, 39.0 [range, birth-90.0 years]). A laboratory-wide association scan revealed a robust association between depression polygenic scores and white blood cell count (β, 0.03; SE, 0.004; P = 1.07 × 10-17), which was replicated in a meta-analysis across the 4 health care systems (β, 0.03; SE, 0.002; P = 1.03 × 10-136). Mediation analyses suggested a bidirectional association, with white blood cell count accounting for 2.5% of the association of depression polygenic score with depression diagnosis (95% CI, 2.2%-20.8%; P = 2.84 × 10-70) and depression diagnosis accounting for 9.8% of the association of depression polygenic score with white blood cell count (95% CI, 8.4%-11.1%; P = 1.78 × 10-44). Mendelian randomization provided additional support for an association between increased white blood count and depression risk, but depression modeled as the exposure showed no evidence of an influence on white blood cell counts.Conclusions and Relevance: This genetic association study found that increased depression polygenic scores were associated with increased white blood cell count, and suggests that this association may be bidirectional. These findings highlight the potential importance of the immune system in the etiology of depression and may motivate future development of clinical biomarkers and targeted treatment options for depression.

White blood cell count as a mediator of the relationship between depressive symptoms and all-cause mortality: A community-based cohort study

The Peripheral Blood Mononuclear Cell Count is Associated with Bone Health in Elderly Men

Cia_a_221917 2273..2280

Depressive symptoms and antidepressant use in relation to white blood cell count among postmenopausal women from the Women's Health Initiative

Depressive symptoms and all-cause mortality among middle-aged and older people in China and associations with chronic diseases

Correlation between white blood cell count at admission and mortality in COVID-19 patients: a retrospective study

Positive Association Between the Metabolic Syndrome and White Blood Cell Counts in Chinese.

White blood cell counts can predict 4-year cardiovascular disease risk in patients with stable coronary heart disease: a prospective cohort study

The Mediation Effect of Cotinine Between Depression, Inflammation, and Mortality: A National Cohort Study

Association of depressive symptoms with cardiovascular events and plasma BNP: A prospective cohort study of the elderly Chinese population

Association Between Multimorbidity and Depressive Symptom Among Community-Dwelling Elders in Eastern China.

Relaitonship of mean platelet volume to MDD: a retrospecitve study

Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome

White blood cell count associates with peripheral arterial disease in a Chinese community-based population

Association between subjective well-being and all-cause mortality among older adults in China

Mediating effects of depressive symptoms on social support and quality of life among rural older Chinese.

Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count

White blood cell count predicts the odds of kidney function decline in a Chinese community-based population

Association between hematological parameters and metabolic syndrome components in a Chinese population

Bidirectional relationship between C-reactive protein and depressive symptoms considering cumulative effect among Chinese middle-aged and older adults

The positive association between white blood cell count and metabolic syndrome is independent of insulin resistance among a Chinese population: a cross-sectional study